About Us

Meet the Team

SeqOnce is accelerating life science discoveries and improving the human condition. From NGS to new detection technologies, we unlock hidden potential in existing platforms.

Real-world solutions for real-world science.

Founded in 2014, SeqOnce was spun out of USC and is privately held. The founders have complementary skill sets with CSO Joseph Dunham’s strong background in molecular biology and technology development and CEO Chris Angermayer’s expertise in finance and operations. SeqOnce is growing rapidly as it continues to launch new products in genomics, food safety, and pathogen detection.

Want to accelerate your sequencer? How about your career?

Advisors

Scott Tighe, PhD

Scott Fraser, PhD

Martin Pieprzyk

Board Members

Chris Angermeyer

Joe Dunham, PhD

Michael Giardello, PhD

Chris Angermayer

CHIEF EXECUTIVE OFFICER & CO-FOUNDER
Linkedin

Joseph P. Dunham, PhD

CHIEF SCIENCE OFFICER & CO-FOUNDER
Linkedin

Tim Harkins, PhD

CHIEF OPERATIONS OFFICER
Linkedin

Lyle Rawlings, MB(ASCP), TS

SENIOR DIRECTOR OF ASSAY DEVELOPMENT
Linkedin
Contact
Distributors
About
About Us
Conservation
Copyright 2023 Seqonce Biosciences. All Rights Reserved. Provisional Owner/Operator FDA Registration Number: 10076042 Designed by Hubble Design Group. Built & Managed by MITO Studios